REPH
Recro Pharma, Inc.
Possible Member of 10% Group, 10% James E Flynn sold $706K of Recro Pharma, Inc.
Sold$706,226
$6.39Price
110,447Shares
−5%Stake
What REPH did after the filing
Prices for REPH after this filing aren't in yet.
Traded Mon, Jun 12. Filed Wed, Jun 14, 8:13 PM ET, after the close. Not investment advice.